Adjuvant systemic treatment of premenopausal women with hormone receptor-positive early breast cancer: Lights and shadows

Grants

Funding Acknowledgements

We thank the patients, physicians, nurses, trial coordinators, and pathologists who participated in the Suppression of Ovarian Function Trial (SOFT) and Tamoxifen and Exemestane Trial (TEXT). The trials were conducted by the International Breast Cancer Study Group (IBCSG) in collaboration with the Breast International Group (BIG), BIG cooperative groups, and US National Cancer Institute National Clinical Trials Network cooperative groups. SOFT and TEXT receive financial support for trial conduct and long-term follow-up from Pfizer, Ipsen, TerSera, Breast Cancer Research Foundation, and IBCSG. Pfizer and Ipsen provided drug supply.